Former Organon Exec Will Help Drive Company's Commercialization of Eligen(R) Technology
CEDAR KNOLLS, N.J., Aug. 19 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS) has announced that Nicholas J. Hart has joined the company as Vice President of Strategy and Development. In this capacity, Mr. Hart will be responsible for the planning and commercial development aspects of the company's Eligen(R) technology, including Eligen(R) B12.
Mr. Hart comes to Emisphere with over 16 years of commercial experience in the pharmaceutical industry. In his most recent capacity at Organon, part of Schering Plough Corporation, he was Leader of the Contraception Therapy Area and a member of the Corporate Executive Leadership Team. Also at Organon, he served as Senior Director/Executive Director of Marketing of the Women's Healthcare Franchise; Director of CNS Marketing, and Associate Director of Specialty Products. Prior to Organon, Mr. Hart held various marketing and sales positions with Novartis, Sankyo Parke Davis Pharmaceuticals, and Bristol-Myers Squibb Company.
After graduating from the United States Military Academy at West Point, Mr. Hart received an MBA in Finance and International Business from New York University, Stern School of Business. He also served as a Field Artillery Officer in the United States Army.
"I am delighted Nick Hart has joined our team at Emisphere to help us
commercialize our Eligen(R) Technology, including Eligen(R) B12," said
Michael V. Novinski, President and Chief Executive Officer of Emisphere.
"He brings a tremendous wealth of experience and a successful track record
of accomplishment in the pharmaceutical industry. He has a demonstrated
skill set both strategically and oper
|SOURCE Emisphere Technologies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved